Using Effective Risk Communication to Increase Vaccination Rates
Organization: Canadian Public Health Association (CPHA)Published: 2021
"This webinar will provide insights on:
- the impact of the COVID-19 pandemic on immunization and vaccine confidence;
- how to summarize evidence about these vaccines and present it in plain language;
- how to communicate numbers and probabilities appropriately;
- ways in which problems with communicating about uncertainty can be avoided;
- using comparisons effectively;
- countering misinformation;
- tools and methods that can be used to craft and evaluate key messages before disseminating them; and
- strategies to optimize vaccine conversations and build vaccine confidence to support continued immunization against all vaccine-preventable diseases."
Resource Group:
Implementation Tool
Product Type: Webinar
Sub Topics: Vaccination Decision Making
Understanding Vaccine Hesitancy
Misinformation/Disinformation
Vaccine Acceptance and Uptake
Counselling and Communication
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Product Type: Webinar
Category:
Vaccination Decision Making,Sub Topics: Vaccination Decision Making,Understanding Vaccine Hesitancy,Misinformation/Disinformation,Vaccine Acceptance and Uptake,Counselling and Communication,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccination Decision MakingSub Topics: Vaccination Decision Making
Understanding Vaccine Hesitancy
Misinformation/Disinformation
Vaccine Acceptance and Uptake
Counselling and Communication
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Language:
English
Resource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.